Fmoc-TOAC-OH
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc-TOAC-OH

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

A stable free radical spin label.

Category
Fmoc-Amino Acids
Catalog number
BAT-005268
CAS number
93372-25-9
Molecular Formula
C25H29N2O5
Molecular Weight
437.51
Fmoc-TOAC-OH
Synonyms
2,2,6,6-Tetramethylpiperidine-N-oxyl-4-(9-fluorenylmethyloxycarbonyl-amino)-4-carboxylic acid; 4-(9H-fluoren-9-ylmethoxycarbonylamino)-2,2,6,6-tetramethyl-1-oxidopiperidin-1-ium-4-carboxylic acid; 4-((9-fluorenylmethyloxycarbonyl)amino)-4-carboxy-2,2,6,6-tetramethylpiperidine-N-oxyl; Fmoc-2,2,6,6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid
Appearance
Light yellow crystalline powder
Purity
≥ 98% (HPLC)
Melting Point
159-170 °C
Storage
Store at -20 °C
1. Synthesis of TOAC spin-labeled proteins and reconstitution in lipid membranes
Christine B Karim, Zhiwen Zhang, David D Thomas Nat Protoc. 2007;2(1):42-9. doi: 10.1038/nprot.2007.2.
A procedure is described for the synthetic incorporation into membrane proteins of the non-natural amino acid TOAC (2,2,6,6-tetramethyl-piperidine-1-oxyl-4-amino-4-carboxylic acid), which is coupled rigidly to the alpha-carbon, providing direct detection of peptide backbone dynamics by electron paramagnetic resonance (EPR). Also included is a protocol for the functional reconstitution of the spin-labeled protein in lipid vesicles. This protocol can be completed in 17 d.
2. Electron paramagnetic resonance backbone dynamics studies on spin-labelled neuropeptide Y analogues
Andrea Bettio, Volker Gutewort, Andreas Pöppl, Michaela C Dinger, Olaf Zschörnig, Arnold Klaus, Claudio Toniolo, Annette G Beck-Sickinger J Pept Sci. 2002 Dec;8(12):671-82. doi: 10.1002/psc.428.
Neuropeptide Y (NPY) is one of the most abundant peptides in the central nervous system of mammalians. NPY acts by binding to at least five G-protein coupled receptors (GPCRs) which have been named Y1, Y2, Y4, Y5 and Y6. Three spin-labelled NPY analogues containing the nitroxide group of the amino acid TOAC (2.2.6.6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid) as a paramagnetic probe were synthesized by solid-phase peptide synthesis. Synthetic problems owing to the sensitivity of nitroxide towards acidic and reducing conditions have been overcome by using a cleavage cocktail that contains anisole and cresol scavengers. Concerning the receptor binding preferences, the analogues [TOAC34]-pNPY and [Ala31, TOAC32]-pNPY showed a marked selectivity for the Y5 receptor, while [TOAC2]-pNPY maintained a significant binding also to the Y2 receptor subtype. The modifications of the native peptide structure caused by the introduction of TOAC were examined by circular dichroism. In order to determine the rotational correlation time of the spin probes, electron paramagnetic resonance measurements were performed in solution and in the presence of liposomes. This allowed us to evaluate the backbone dynamics of the different parts of the NPY molecule in the free and membrane bound states. The results of these studies showed that NPY Interacts with liposomes by using the C-terminal alpha-helix while the N-terminal tail retains a flexibility that is comparable to that of the peptide in solution as already shown by NMR studies on DPC micelles. Furthermore, we demonstrated that TOAC-labelllng is a valuable tool to investigate changes in the backbone conformation and dynamics. This may be of major importance for peptides and small proteins when they bind to cell membranes.
3. Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone
Christine B Karim, Tara L Kirby, Zhiwen Zhang, Yuri Nesmelov, David D Thomas Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14437-42. doi: 10.1073/pnas.0402801101. Epub 2004 Sep 24.
We have used chemical synthesis and electron paramagnetic resonance to probe the structural dynamics of phospholamban (PLB) in lipid bilayers. Derivatives of monomeric PLB were synthesized, each of which contained a single spin-labeled 2,2,6,6,-Tetramethyl-piperidine-N-oxyl-4-amino-4-carboxylic acid amino acid, with the nitroxide-containing ring covalently and rigidly attached to the alpha-carbon, providing direct insight into the conformational dynamics of the peptide backbone. 2,2,6,6,-tetramethyl-piperidine-N-oxyl-4-amino-4-carboxylic acid was attached at positions 0, 11, and 24 in the cytoplasmic domain or at position 46 in the transmembrane domain. The electron paramagnetic resonance spectrum of the transmembrane domain site (position 46) indicates a single spectral component corresponding to strong immobilization of the probe, consistent with the presence of a stable and highly ordered transmembrane helix. In contrast, each of the three cytoplasmic domain probes has two clearly resolved spectral components (conformational states), one of which indicates nearly isotropic nanosecond dynamic disorder. For the probe at position 11, an N-terminal lipid anchor shifts the equilibrium toward the restricted component, whereas Mg(2+) shifts it in the opposite direction. Relaxation enhancement, due to Ni(2+) ions chelated to lipid head-groups, provides further information about the membrane topology of PLB, allowing us to confirm and refine a structural model based on previous NMR data. We conclude that the cytoplasmic domain of PLB is in a dynamic equilibrium between an ordered conformation, which is in direct contact with the membrane surface, and a dynamically disordered form, which is detached from the membrane and poised to interact with its regulatory target.
Online Inquiry
Verification code
Inquiry Basket